Jane Street’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Jane Street’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,740	Closed	-$1.06M	–	9717
2023 Q2	$1.06M	Buy	22,740 +10,032	+79%	+$347K	﹤0.01%	5110
2023 Q1	$364K	Sell	12,708 -3,410	-21%	-$101K	﹤0.01%	6866
2022 Q4	$503K	Buy	+16,118	New	+$526K	﹤0.01%	6135

Jane Street's DICE Position: Q3 2023 in Review

Jane Street sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 22,740 shares — an estimated $1.06M sold.

Jane Street first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $1.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Jane Street reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Jane Street sold 22,740 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.06M.
Jane Street first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Jane Street's DICE Therapeutics, Inc. Common Stock position peaked at $1.06M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.